When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at least a lead drug candidate. Large sums are also often

The mother sitting across from me had done everything right. She noticed the signs early and pushed for an evaluation. She worked with her insurance company and eventually secured a

MedCity News has long covered innovation in healthcare. We have also hosted events bringing together investors, startups and the healthcare ecosystem in a bid to connect those novel companies to

The Trump administration recently released a proposed rule that aims to expand access to fertility benefits, but some healthcare leaders say it doesn’t go far enough. The rule proposed by

The CDC estimates that more than 129 million Americans, roughly 37% of the population, are living with at least one chronic condition. These conditions account for nearly 90% of the

Beth Israel Lahey Health recently modernized its fax infrastructure — a move the Massachusetts-based health system said has paid off big time. The health system upgraded its faxing processes during

The high cost of GLP-1s is causing some employers to reconsider their coverage, a new survey from the Business Group on Health found. The survey received responses from 105 self-funded

Critical care transport is one of the most intense and demanding parts of emergency medical services. We’re talking about patients in the most fragile situations: premature newborns, trauma victims, or

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. The DOJ rolled out a strike

Immunology continues to be one of the hottest areas for biotech investment, and Windward Bio is joining in with $165 in fresh capital to support a pipeline led by a